Presence of concomitant inflammatory bowel disease is associated with an increased risk of postcholecystectomy complications

Inflammatory Bowel Diseases

Volumn 18, Issue 9, 2012, Pages 1682-1688

  Navaneethan, Udayakumar ^a   Choure, Anuja ^a   Venkatesh, Preethi G K ^a   Hammel, Jeffrey ^a   Lin, Jingmei ^a   Goldblum, John R ^a   Manilich, Elena ^a   Kiran, Ravi P ^a   Remzi, Feza H ^a   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cholecystectomy; complications; inflammatory bowel diseases; primary sclerosing cholangitis; ulcerative colitis

Indexed keywords

CORTICOSTEROID; IMMUNOMODULATING AGENT; NARCOTIC AGENT;

ABDOMINAL ABSCESS; ABDOMINAL PAIN; ABDOMINAL SURGERY; ACUTE CHOLECYSTITIS; ADULT; ARTICLE; BILE DUCT INJURY; BILE LEAKAGE; BILOMA; BIOLOGICAL THERAPY; CHOLECYSTECTOMY; CHOLELITHIASIS; CHRONIC CHOLECYSTITIS; COMMON BILE DUCT STONE; CONTROLLED STUDY; CROHN DISEASE; DIABETES MELLITUS; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; FISTULA; GALLBLADDER DISEASE; GALLBLADDER DYSKINESIA; GALLBLADDER POLYP; GALLSTONE; HEPATIC DUCT; HEPATIC DUCT INJURY; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; LIVER CIRRHOSIS; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SMALL INTESTINE OBSTRUCTION; SURGICAL MORTALITY; SURGICAL RISK; TOTAL PARENTERAL NUTRITION; TREATMENT INDICATION; ULCERATIVE COLITIS; UROGENITAL TRACT DISEASE; WOUND INFECTION;

CASE-CONTROL STUDIES; CHOLECYSTECTOMY; FEMALE; GALLSTONES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS;

EID: 84865036725     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21917     Document Type: Article

References (24)

1. Ahrendt SA, Pitt HA,. Calculous biliary disease. In:, Townsend CM, Beauchamp RD, Evers BM, et al, eds. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice, 17th ed. Philadelphia: Saunders; 2007: 1612-1615.
2. Loftus EV Jr,. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126: 1504-1517.
3. Navaneethan U, Shen B,. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis. 2010; 16: 1598-1619.
4. Fraquelli M, Losco A, Visentin S, et al. Gallstone disease and related risk factors in patients with Crohn's disease: analysis of 330 consecutive cases. Arch Intern Med. 2001; 161: 2201-2204.
5. Alves A, Panis Y, Bouhnik Y, et al. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum. 2007; 50: 331-336.
6. Heuschen UA, Allemeyer EH, Hinz U, et al. Outcome after septic complications in J pouch procedures. Br J Surg. 2002; 89: 194-200.
7. Yamamoto T, Allan RN, Keighley MR,. Risk factors for intraabdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum. 2000; 43: 1141-1145.
8. Alavi K, Sturrock PR, Sweeney WB, et al. A simple risk score for predicting surgical site infections in inflammatory bowel disease. Dis Colon Rectum. 2010; 53: 1480-1486.
9. Beddy D, Dozois EJ, Pemberton JH,. Perioperative complications in inflammatory bowel disease. Inflamm Bowel Dis. 2011; 17: 1610-1619.
10. Aberra FN, Lewis JD, Hass D, et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology. 2003; 125: 320-327.
11. Lim M, Sagar P, Abdulgader A, et al. The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis. Dis Colon Rectum. 2007; 50: 943-951.
12. Subramanian V, Saxena S, Kang JY, et al. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol. 2008; 103: 2373-2381.
13. Post S, Betzler M, von Ditfurth B, et al. Risks of intestinal anastomosis in Crohn's disease. Ann Surg. 1991; 213: 37-42.
14. Csikesz N, Ricciardi R, Tseng JF, et al. Current status of surgical management of acute cholecystitis in the United States. World J Surg. 2008; 32: 2230-2236.
15. Murphy MM, Shah SA, Simons JP, et al. Predicting major complications after laparoscopic cholecystectomy: a simple risk score. J Gastrointest Surg. 2009; 13: 1929-1936.
16. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control. 1988; 16: 128-140.
17. Appau KA, Fazio VW, Shen B, et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg. 2008; 12: 1738-1744.
18. Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg. 2007; 204: 956-962.
19. Mor IJ, Vogel JD, da Luz Moreira A, et al. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum. 2008; 51: 1202-1207.
20. Nguyen GC, Laveist TA, Segev DL, et al. Race is a predictor of in-hospital mortality after cholecystectomy, especially in those with portal hypertension. Clin Gastroenterol Hepatol. 2008; 6: 1146-1154.
21. Ananthakrishnan AN, McGinley EL, Saeian K, et al. Laparoscopic resection for inflammatory bowel disease: outcomes from a nationwide sample. J Gastrointest Surg. 2010; 14: 58-65.
22. Giger UF, Michel JM, Opitz I, et al. Risk factors for perioperative complications in patients undergoing laparoscopic cholecystectomy: analysis of 22,953 consecutive cases from the Swiss Association of Laparoscopic and Thoracoscopic Surgery database. J Am Coll Surg. 2006; 203: 723-728.
23. Nguyen GC, Leung W, Weizman AV,. Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2011; 17: 1338-1342.
24. Karagozian R, Johannes RS, Sun X, et al. Increased mortality and length of stay among patients with inflammatory bowel disease and hospital-acquired infections. Clin Gastroenterol Hepatol. 2010; 8: 61-65.